AI-generated analysis. Always verify with the original filing.
Pulse Biosciences, Inc. issued a press release on March 12, 2026, announcing the first enrollment of patients in an investigator-initiated clinical study. This event was disclosed under Item 8.01 Other Events with Exhibit 99.1.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On March 12, 2026, Pulse Biosciences, Inc. (the “Company”) issued a press release announcing the first enrollment of patients in the investigator
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Pulse Biosciences, Inc. dated March 12, 2026 - Pulse Bio